Depression in adults: treatment and management (NG222)Product type:GuidanceProgramme:NICE guidelinePublished: 29 June 2022
Esketamine for treatment-resistant depression [ID1414]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC